Stenting for renal artery stenosis is well described in the literature. Bilateral renal artery stenting is not such a common procedure, however it is quite rare in patients with Leriche syndrome, as is the case we present.

1.
Losinno F, Zuccala A, Busato F, Zucchelli P: Renal artery angioplasty for renovascular hypertension and preservation of renal function: Long-term angiographic and clinical follow-up. AJR 1994;162:853–857.
2.
Connoly JQ, Higgins RM, Walters HL, et al: Presentations, clinical features and outcome in different patients of atherosclerotic renovascular disease. Q J Med 1994;87:413–421.
3.
Guzman RP, Zierler RE, Isaacson JA, Bergelin RO, Strandneis DE: Renal atrophy and arterial stenosis: A prospective study with duplex ultrasound. Hypertension 1994;23:346–350.
4.
Martin LG, price RB, Casarella WJ, et al: Percutaneous angioplasty in clinical management of renovascular hypertension: Initial and long-term results. Radiology 1989;171:501.
5.
Doros G, Jaff M, Jain A, Duffcic C, Mathiak L: Follow up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis. Am J Cardiol 1995;75:1051–1055.
6.
Rundback J, Gray R, Rozenblit G, et al: Renal artery stent placement for the management of ischemic nephropathy. JVIR 1998;9(suppl 3):413–418.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.